ArticleFrontiers in oncology2021

Survival After Combining Stereotactic Body Radiation Therapy and Tyrosine Kinase Inhibitors in Patients With Metastatic Renal Cell Carcinoma.

Yang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.